These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36071112)

  • 1. ABCB1 variants and sex affect serotonin transporter occupancy in the brain.
    Silberbauer LR; Rischka L; Vraka C; Hartmann AM; Godbersen GM; Philippe C; Pacher D; Nics L; Klöbl M; Unterholzner J; Stimpfl T; Wadsak W; Hahn A; Hacker M; Rujescu D; Kasper S; Lanzenberger R; Gryglewski G
    Mol Psychiatry; 2022 Nov; 27(11):4502-4509. PubMed ID: 36071112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
    Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
    Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
    Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
    Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.
    Hinz R; Selvaraj S; Murthy NV; Bhagwagar Z; Taylor M; Cowen PJ; Grasby PM
    J Cereb Blood Flow Metab; 2008 Aug; 28(8):1478-90. PubMed ID: 18478022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [
    Kim E; Howes OD; Kim BH; Chon MW; Seo S; Turkheimer FE; Lee JS; Lee YS; Kwon JS
    Clin Pharmacokinet; 2017 Apr; 56(4):371-381. PubMed ID: 27557550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
    Schrantee A; Lucassen PJ; Booij J; Reneman L
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
    Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
    Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
    Singh AB; Bousman CA; Ng CH; Byron K; Berk M
    Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [(11)C]DASB.
    Arakawa R; Tateno A; Kim W; Sakayori T; Ogawa K; Okubo Y
    Psychiatry Res Neuroimaging; 2016 May; 251():1-6. PubMed ID: 27082864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET.
    Baldinger P; Kranz GS; Haeusler D; Savli M; Spies M; Philippe C; Hahn A; Höflich A; Wadsak W; Mitterhauser M; Lanzenberger R; Kasper S
    Neuroimage; 2014 Mar; 88():252-62. PubMed ID: 24121201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.
    Meyer JH; Wilson AA; Ginovart N; Goulding V; Hussey D; Hood K; Houle S
    Am J Psychiatry; 2001 Nov; 158(11):1843-9. PubMed ID: 11691690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.